Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Coupang Inc (CPNG) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance

Coupang IncTrade
SELLAS Life Sciences Group Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Coupang Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Coupang Inc trades at $15.78 (market cap $27.70B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B). The key difference: Coupang Inc is far larger — about 12.2× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Coupang Inc nearer its low. Which is the better fit depends on your goals.

CPNGSLS
Market Cap
$27.70B$2.27B
Volume
27,703,6084,179,659
Sector
Consumer CyclicalHealth
52-Week High
$32.47$15.46
52-Week Low
$13.75$1.39
Enterprise Value
$27.22B$2.14B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Coupang Inc

CPNG trades at $15.83, up 6.89% over 24 hours, with a bullish technical signal from moving averages and ADX. The company reported $34.53B revenue in 2025 with a net income of $208M, though recent quarters show earnings misses. Analyst consensus is strongly bullish with a $25.25 price target, and cash flow from operations remains positive at $1.77B.

The outlook is mixed: strong revenue growth and analyst support offer upside, but negative net income margin and high P/E of 184.18 signal overvaluation risks. Key risks include competitive pressure from MercadoLibre and Alibaba, and a projected net loss of $767M in 2026. Institutional sentiment is positive, but earnings volatility requires caution.

SELLAS Life Sciences Group Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CPNG
100% Buy0% Sell
SLS

No sentiment data available yet.

About Coupang Inc

Coupang Inc is an e-commerce company. The company sells apparel, electronics, footwear, food products, furniture, nutritional supplements, and other products. Its segments include Product Commerce and Growth Initiatives.

Read more on CPNG →

About SELLAS Life Sciences Group Inc. Common Stock

SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.

Read more on SLS →